Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome

NCT00373451 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1721

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Coronary Disease

Interventions

DRUG: Abciximab + UFH
DRUG: Bivalirudin
DRUG: Heparin

Sponsor

Deutsches Herzzentrum Muenchen